Results demonstrate Esopredict's ability to predict the likelihood of progression to high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's…
SALT LAKE CITY, Aug. 15, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a…
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- The global chromatography market size is estimated to grow by USD 3.99 billion…
Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024…
Declared development candidate MGX-001 for the treatment of hemophilia A; plans to present 12-month NHP durability study data in September…
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:…
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun…
BOSTON, MA / ACCESSWIRE / August 13, 2024 / Colorectal cancer, a serious condition affecting the colon or rectum, is…
iReferral® automatically identifies potential organ and tissue donors and streamlines the hospital-to-OPO referral process. ANN ARBOR, Mich., Aug. 13, 2024…
Company to Focus on Targeted Promotion of INPEFA® in Heart Failure While Prioritizing Investment in the Potential Launch of ZYNQUISTA™…